IE903449A1 - New imidazolepropanamide derivative, its preparation and its¹use - Google Patents

New imidazolepropanamide derivative, its preparation and its¹use

Info

Publication number
IE903449A1
IE903449A1 IE344990A IE344990A IE903449A1 IE 903449 A1 IE903449 A1 IE 903449A1 IE 344990 A IE344990 A IE 344990A IE 344990 A IE344990 A IE 344990A IE 903449 A1 IE903449 A1 IE 903449A1
Authority
IE
Ireland
Prior art keywords
product
radical
amino
formula
process according
Prior art date
Application number
IE344990A
Other languages
English (en)
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of IE903449A1 publication Critical patent/IE903449A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/16—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/46—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE344990A 1989-09-26 1990-09-25 New imidazolepropanamide derivative, its preparation and its¹use IE903449A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8912574A FR2652351A1 (fr) 1989-09-26 1989-09-26 Nouveau derive de l'imidazolepropanamide, sa preparation et son emploi.

Publications (1)

Publication Number Publication Date
IE903449A1 true IE903449A1 (en) 1991-04-10

Family

ID=9385817

Family Applications (1)

Application Number Title Priority Date Filing Date
IE344990A IE903449A1 (en) 1989-09-26 1990-09-25 New imidazolepropanamide derivative, its preparation and its¹use

Country Status (9)

Country Link
JP (1) JPH03120258A (hu)
CA (1) CA2026128A1 (hu)
FI (1) FI904707A0 (hu)
FR (1) FR2652351A1 (hu)
HU (1) HU906213D0 (hu)
IE (1) IE903449A1 (hu)
IL (1) IL95761A0 (hu)
NO (1) NO904168L (hu)
PT (1) PT95419A (hu)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585020B1 (fr) * 1985-07-18 1987-10-02 Rhone Poulenc Sante Nouvelle substance biologiquement active, appelee girolline, extraite de l'eponge pseudaxinyssa cantharella, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
IL95761A0 (en) 1991-06-30
PT95419A (pt) 1991-05-22
NO904168L (no) 1991-03-27
HU906213D0 (en) 1991-03-28
FR2652351A1 (fr) 1991-03-29
NO904168D0 (no) 1990-09-25
JPH03120258A (ja) 1991-05-22
FI904707A0 (fi) 1990-09-25
CA2026128A1 (fr) 1991-03-27

Similar Documents

Publication Publication Date Title
EP0698606B1 (en) Azolylamine derivative
EP0173199B1 (de) cis, endo-2-Azabicycloalkan-3-carbonsäure-Derivate, Verfahren zu deren Herstellung, deren Verwendung sowie Zwischenprodukte bei deren Herstellung
KR100467898B1 (ko) 티아졸리딘의 제조 방법
EP0071904A1 (de) Neue Diglycidyl-substituierte heterocyclische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittelzubereitungen mit cytostatischer Wirksamkeit
EP1382333B1 (en) Use of beta 3 adrenergic receptor agonists in the treatment of dysuria
EP0523449B1 (de) Reduktive Aminierung einer Aminosäure oder eines Aminosäure-Derivates mit einer Alpha-Ketosäure oder einem Alpha-Ketosäurederivat
EP0603414B1 (en) (-)-ritodrine
BG64701B1 (bg) Метод за получаване на 2-азадихидроксибицикло[2.2.1]хептаново съединение и сол на съединението и l-винена киселина
DE60004126T2 (de) Verfahren zur Herstellung von (1R, 2S, 4R)-(-)-2-[(2'-(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptan und ihre pharmazeutisch akzeptierbaren Säure-Additions-Salze
IE903449A1 (en) New imidazolepropanamide derivative, its preparation and its¹use
JP3598133B2 (ja) 水素化方法
EP0432899A1 (en) Novel pharmaceutical epinephrine-pilocarpine derivatives
EP0426762B1 (de) Verfahren zur herstellung von dipeptiden mit c-terminalen nicht-proteinogenen aminosäuren
FR2623504A1 (fr) Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US3745171A (en) 1-(pentyl or hexyl)-3-alkyl-3-(m-hydroxyphenyl)-pyrrolidines
EP0437690A2 (de) Verfahren zur asymmetrischen Hydrierung von alpha-Ketocarbonyl-verbindungen zu optisch aktiven alpha-Hydroxycarbonylverbindungen
US5238955A (en) Ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkylethylenediamines
EP1076646B1 (de) Verfahren zur stereochemisch kontrollierten herstellung isomerenreiner hochsubstituierter azacyclischer verbindungen
WO1994007841A1 (de) Verfahren zur reduktion von carbonsäuren oder carbonsäurederivaten sowie neue verbindungen
HU193615B (en) Process for production of derivatives of optically active asolile-carbinol and medical compounds containing thereof
Lorenzin et al. The reaction of primary. beta.-azido tertiary alcohols with nitrosonium salts. A rearrangement related to the Tiffeneau reaction
EP0403318A1 (fr) Procédé de préparation d'une nouvelle substance antitumorale, l'amino-3 (amino-2 1H-imidazolyl-4-)-1 chloro-2 propanol-1 et de ses sels sous forme racémique thréo, utilisable comme médicament
Ketter et al. Alkoxymethylation of ferrocenylalkenes
US5952376A (en) Trienyl compounds
KR800000537B1 (ko) 아미노-페닐-에탄올아민의 제조방법